Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Buybacks are possible

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Jun 17, 2024 9:40am

77 Views

Post# 36091850

RE:RE:Buybacks are possible

mdjbrown wrote: QC1, Verano appears to be in a much better stage of revenue growth making a NCIB shareholder friendly with minimal risk. Not sure Medipharm can say the same at the moment ..............

Shares Out 346.42 Million

Verano Announces Revised Fourth Quarter

Record Revenue of $938 Million
Increased 2023 Net Cash Provided by Operating Activities by 16% to $110 Million Generated $73 million in Free Cash Flow1 for 2023, Meeting Guidance

Not claiming that they are is a different stage than LABS, but certainly if LABS are accurate in their profitability projections, then the risk of doing a buyback with some of the treasury is also low.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?